ABT
Abbott Laboratories
Stock
$96.69−2.14 (−2.17%)Close Oct 1, 2026
| EBITDA (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $8.9B | −0.1% | 7.7% | 9.8% |
| EBITDA (TTM) | $8.9B |
|---|---|
| YoY | −0.1% |
| 5-year CAGR | 7.7% |
| 10-year CAGR | 9.8% |
EBITDA
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $9.5B | +16.2% |
| 2024 | $8.2B | +5.3% |
| 2023 | $7.8B | −19.4% |
| 2022 | $9.6B | −3.0% |
| 2021 | $9.9B | +51.3% |
| 2020 | $6.6B | +16.8% |
| 2019 | $5.6B | +18.1% |
| 2018 | $4.8B | +82.0% |
| 2017 | $2.6B | −31.8% |
| 2016 | $3.8B | +2.4% |
| 2015 | $3.7B | +6.3% |
| 2014 | $3.5B | +14.9% |
| 2013 | $3.1B | +12.4% |
| 2012 | $2.7B | −10.0% |
| 2011 | $3.0B | −58.5% |
| 2010 | $7.3B | −2.0% |
| 2009 | $7.4B | +10.4% |
| 2008 | $6.7B | +19.4% |
| 2007 | $5.7B | — |